CRTH2 antagonists in the treatment of allergic responses involving TH2 cells, basophils, and eosinophils

Annals of Allergy, Asthma & Immunology

December 2012 Volume 109, Issue 6, Pages 365-374 CME Review

Overall Purpose
Participants will be able to demonstrate increased knowledge of the clinical treatment of allergy/asthma/immunology and how new information can be applied to their own practices


Accreditation: The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for ContinuingMedical Education (ACCME) to provide continuing medical education for physicians.

Designation: The American College of Allergy, Asthma & Immunology (ACAAI) designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Planning Committee
Robert G. Townley, MD (Senior Author)
Gailen D. Marshall, Jr, MD, PhD (Editor-in-Chief)



Target Audience

Physicians involved in providing patient care in the field of allergy/asthma/immunology

Learning Objectives

At the conclusion of this activity, participants should be able to:
● Discuss the importance of CRTH2 in the cells of the immune system and its role in allergic inflammation
● Describe the role of PGD2 and its receptors as well as its role after it is released from the mast cell 

Additional information

R.G. Townley, S. Agrawal, and G.D. Marshall have nothing to disclose. Reviewers and Education/Editorial staff have no relevant financial relationships to disclose. No unapproved/investigative use of a product/device are discussed

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance
Course opens: 
Course expires: 

Robert G. Townley, MD and Swati Agrawal, MBBS 

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance
Please login or create an account to take this course.